FindTrial
Sign In

Study of personalized precision medicine of immunosuppressive agents after liver transplantation

Study of personalized precision medicine of immunosuppressive agents after liver transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-17012752
Enrollment
Unknown
Registered
2017-09-20
Start date
2017-09-22
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver transplant

Interventions

all sample:no intervention

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18–65 years old; Han ethnic; no serverity complications such as acute rejection or severe infection.

Exclusion criteria

Exclusion criteria: retransplanted patients; combined organ transplanted patients; receiving co-medication drugs known to interfere with the transport and metabolism of FK506 or have a potential effect on drug metabolizing enzymes; medication nonadherence.

Design outcomes

Primary

MeasureTime frame
genotype;—

Countries

China

Contacts

Public ContactDexi Chen

The Affiliated Hospital of Qingdao University

zyjnsfc@126.com+86 15810333799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026